Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29396
Title: | Current aspects of TIA management. | Authors: | Srikanth V.;Ma H. ;Singhal S.;Ly J.;Phan T.G.;Clissold B. | Monash Health Department(s): | Neurology | Institution: | (Clissold, Phan, Ly, Singhal, Srikanth, Ma) Stroke Unit, Department of Neurosciences, Monash Medical Centre and Stroke and Aging Research Group, Department of Medicine, Monash University, Australia | Issue Date: | 17-Feb-2020 | Copyright year: | 2020 | Publisher: | Churchill Livingstone | Place of publication: | United Kingdom | Publication information: | Journal of Clinical Neuroscience. 72 (pp 20-25), 2020. Date of Publication: February 2020. | Journal: | Journal of Clinical Neuroscience | Abstract: | Transient Ischaemic Attack (TIA) if untreated carries a high risk of early stroke and is associated with poorer long-term survival [1]. There is emerging evidence of a reduction in stroke risk following TIA. Time critical investigations and management, as well as service organisation remain key to achieving good outcomes. Patients are diagnosed with TIA if they have transient, sudden-onset focal neurological symptoms which usually completely and rapidly resolve by presentation. The tissue based definition of TIA guides the fact that patients with residual symptoms should be considered as potentially having a stroke, with urgent evaluation regarding eligibility for thrombolysis and/or endovascular clot retrieval (ECR). Essential investigations for all patients with TIA should include early brain imaging, ECG, and carotid imaging in patients with anterior circulation symptoms. After brain imaging, exclusion of high risk indicators and immediate administration of an antiplatelet agent, subsequent attention to other mechanistic factors can be managed safely as part of a structured clinical pathway supervised by stroke specialists. This is in line with the recently revised Stroke Foundation Clinical Guidelines for Stroke Management (2017).Copyright © 2019 Elsevier Ltd | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.jocn.2019.12.032 | PubMed URL: | 31911111 [http://www.ncbi.nlm.nih.gov/pubmed/?term=31911111] | ISSN: | 0967-5868 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/29396 | Type: | Review | Subjects: | risk factor *transient ischemic attack/dt [Drug Therapy] *transient ischemic attack/th [Therapy] acetylsalicylic acid/dt [Drug Therapy] antithrombocytic agent/dt [Drug Therapy] atorvastatin/dt [Drug Therapy] clopidogrel/dt [Drug Therapy] glucose/ec [Endogenous Compound] medical specialist blood clot lysis brain radiography cerebrovascular accident/dt [Drug Therapy] clinical assessment tool clinical feature electrocardiogram glucose blood level health service high risk population hospital admission human lifestyle modification neuroimaging outpatient care practice guideline priority journal prognosis review transient ischemic attack acetylsalicylic acid antithrombocytic agent atorvastatin clopidogrel glucose medical specialist blood clot lysis brain radiography cerebrovascular accident tool electrocardiogram glucose blood level health service high risk hospital admission lifestyle modification neuroimaging outpatient care practice guideline human lifestyle modification medical specialist neuroimaging outpatient care practice guideline priority journal prognosis brain radiography risk factor *transient ischemic attack / *drug therapy / *therapy blood clot lysis Review cerebrovascular accident / drug therapy clinical assessment tool clinical feature electrocardiogram glucose blood level health service high risk population hospital admission |
Type of Clinical Study or Trial: | Review article (e.g. literature review, narrative review) |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.